Search

Search results

1. The Misguided War Against Medicines 2008

   Government spending on all types of prescription drugs (patented and non-patented) is increasing faster than any other component of health spending. And new or patented medicines tend to be more expensive compared to older drugs and other health ...

2. Access Delayed, Access Denied: Waiting for New Medicines in Canada 2008

   This is the Fraser Institute's second annual report on the amount of time patients must wait to access new medicines in Canada. The purpose of this report is: (1) to draw attention to the impact that Canadian public policies and institutions have on ...

3. Seniors and Drug Prices in Canada and the United States

   This paper compares Canada-US price differences for the drugs that were most important to Canadian seniors (aged 60 and older) in 2006. Prices are compared separately for brand name and generic prescription drugs. https://www.fraserinstitute.org/sites ...

4. Paying More, Getting Less 2007

   This is the Fraser Institute's fourth annual report on the financial sustainability of health spending by provincial governments in Canada. The report uses a moving-trend analysis to measure sustainability. The trend is derived from the average, ...

5. Cost Burden of Prescription Drug Spending in Canada and the United States, 2007 Edition

   Many drugs, generics in particular, are significantly more expensive in Canada than they are in the United States. On balance between the higher prices paid for brand name drugs and the much lower prices paid for generic drugs in the US, Americans spend ...

6. Canada's Drug Price Paradox, 2007

   Canadians pay much more than Americans for generic drugs because government policies in Canada distort the market for prescription medicines. In currency-equivalent terms, Canadian retail prices for generic prescription drugs in 2006 were on average 115% ...

7. California Dreaming: The Fantasy of a Canadian-Style Health Insurance Monopoly in the United States

   The purpose of this paper is to warn Americans about the dangerous ideas contained in the Universal Health Insurance bill (SB-840) that was recently passed by the Democratic Party majority in the California state legislature and Senate, but which was ...

8. Access Delayed, Access Denied: Waiting for New Medicines in Canada 2007

   This report analyzes the total time patients must wait in Canada to gain access to newly invented pharmaceutical and biological medicines, also known as patented drugs. The purpose of this report is twofold: (1) to draw attention to the impact that ...

9. The Misguided War Against Medicines 2007

   Government spending on all types of prescription drugs (patented and non-patented) is increasing faster than any other component of health spending. And new or patented medicines tend to be more expensive compared to older drugs and other health ...

10. Paying More, Getting Less 2006

    This study is The Fraser Institute's third annual report on the financial sustainability of provincial public health insurance. Every year the data are updated and new projections generated. This year's analysis again uses the most recent five ...